Jiangsu Aidea Pharmaceutical Management
Management criteria checks 1/4
Jiangsu Aidea Pharmaceutical's CEO is Jie Zhang, appointed in Aug 2023, has a tenure of 1.33 years. directly owns 0.027% of the company’s shares, worth CN¥951.36K. The average tenure of the management team and the board of directors is 1.8 years and 4.3 years respectively.
Key information
Jie Zhang
Chief executive officer
CN¥3.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.3yrs |
| CEO ownership | 0.03% |
| Management average tenure | 1.8yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Unpleasant Surprises Could Be In Store For Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) Shares
Oct 16
Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) 30% Share Price Plunge Could Signal Some Risk
Jun 29Jiangsu Aidea Pharmaceutical (SHSE:688488) Is Making Moderate Use Of Debt
Jun 07Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) Shares Climb 27% But Its Business Is Yet to Catch Up
Mar 01CEO
Jie Zhang (54 yo)
1.3yrs
Tenure
CN¥3,013,500
Compensation
Mr. Jie Zhang is CEO & President of Jiangsu Aidea Pharmaceutical Co. Ltd. from August 2023 and has been its Director since March 14, 2023. Mr. Zhang was Executive Vice President of Jiangsu Aidea Pharmaceut...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.3yrs | CN¥3.01m | 0.027% CN¥ 951.4k | |
| VP & Director | 5.8yrs | CN¥872.80k | 0.49% CN¥ 17.5m | |
| Senior Vice President | 2.9yrs | CN¥1.11m | no data | |
| VP & Director | 4.3yrs | CN¥929.00k | 0.0037% CN¥ 129.8k | |
| VP & Director | 1.8yrs | CN¥876.30k | 0.016% CN¥ 576.1k | |
| Vice President | 1.7yrs | CN¥2.46m | no data | |
| Secretary of the Board | 1.7yrs | CN¥679.70k | no data |
1.8yrs
Average Tenure
47yo
Average Age
Experienced Management: 688488's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.8yrs | CN¥3.01m | 0.027% CN¥ 951.4k | |
| VP & Director | 5.8yrs | CN¥872.80k | 0.49% CN¥ 17.5m | |
| VP & Director | 4.3yrs | CN¥929.00k | 0.0037% CN¥ 129.8k | |
| VP & Director | 5.8yrs | CN¥876.30k | 0.016% CN¥ 576.1k | |
| Chairman | 10.9yrs | CN¥1.12m | 0.65% CN¥ 23.2m | |
| Independent Director | 1.3yrs | CN¥29.40k | no data | |
| Chairman of the Supervisory Board | 4.3yrs | no data | 1.2% CN¥ 42.7m | |
| Supervisor | 4.3yrs | no data | no data | |
| Independent Director | 5.6yrs | CN¥100.00k | no data | |
| Independent Director | 2.8yrs | CN¥100.00k | no data |
4.3yrs
Average Tenure
51.5yo
Average Age
Experienced Board: 688488's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 12:35 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Aidea Pharmaceutical Co., Ltd. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |
| Song Yang | Tianfeng Securities Brokerage Co., Ltd |